Indications and Use of GLP-1 Agonists in the Treatment of Type 1 Diabetes in Clinical Practice.

Principal Investigator

Panadeekarn Panjawatanan

Study Number

STUDY02002051

Available at the following location(s)

• Lebanon

Do you need help with some of the labels on this page?
Read our glossary of terms